1. Home
  2. BOF vs GDTC Comparison

BOF vs GDTC Comparison

Compare BOF & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOF
  • GDTC
  • Stock Information
  • Founded
  • BOF 2017
  • GDTC 2018
  • Country
  • BOF United States
  • GDTC Singapore
  • Employees
  • BOF N/A
  • GDTC N/A
  • Industry
  • BOF Packaged Foods
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOF Consumer Staples
  • GDTC Health Care
  • Exchange
  • BOF Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • BOF 27.6M
  • GDTC 24.2M
  • IPO Year
  • BOF 2023
  • GDTC 2023
  • Fundamental
  • Price
  • BOF $2.96
  • GDTC $2.14
  • Analyst Decision
  • BOF
  • GDTC
  • Analyst Count
  • BOF 0
  • GDTC 0
  • Target Price
  • BOF N/A
  • GDTC N/A
  • AVG Volume (30 Days)
  • BOF 3.7M
  • GDTC 205.2K
  • Earning Date
  • BOF 11-13-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • BOF N/A
  • GDTC N/A
  • EPS Growth
  • BOF N/A
  • GDTC N/A
  • EPS
  • BOF N/A
  • GDTC N/A
  • Revenue
  • BOF $10,179,595.00
  • GDTC $573,193.00
  • Revenue This Year
  • BOF N/A
  • GDTC $5.37
  • Revenue Next Year
  • BOF N/A
  • GDTC N/A
  • P/E Ratio
  • BOF N/A
  • GDTC N/A
  • Revenue Growth
  • BOF 95.18
  • GDTC 63.03
  • 52 Week Low
  • BOF $1.52
  • GDTC $1.65
  • 52 Week High
  • BOF $3.21
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • BOF 70.89
  • GDTC 46.24
  • Support Level
  • BOF $2.00
  • GDTC $2.18
  • Resistance Level
  • BOF $3.21
  • GDTC $3.68
  • Average True Range (ATR)
  • BOF 0.23
  • GDTC 0.30
  • MACD
  • BOF 0.08
  • GDTC -0.03
  • Stochastic Oscillator
  • BOF 85.23
  • GDTC 13.97

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: